搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
1 小时
A 'perfect storm' of mutations: How chronic hepatitis C infection leads to autoimmune disease
Scientists at the Garvan Institute of Medical Research have discovered how a viral infection causes autoimmune disease, ...
emjreviews.com
3 小时
Salivary Biomarkers Aid in Sjögren’s Detection
Discover a non-invasive diagnostic model for primary Sjögren’s disease using salivary biomarkers, serum autoantibodies, and ...
Lupus Foundation of America
17 小时
UPDATE: Phase 1 Trial Begins for Investigational CAR-T Therapy, CB-010, for Lupus Nephritis ...
The Phase 1 GALLOP study evaluating the investigational CAR-T therapy, CB-010, for treatment of lupus nephritis has launched.
20 小时
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting ...
1 天
Evercore ISI Sticks to Its Buy Rating for Vera Therapeutics (VERA)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vera Therapeutics (VERA – Research Report) today and set a price target of $75.00.
infectiousdiseaseadvisor.com
1 天
Antiarrestin Autoantibodies Are Potential Biomarkers of HCQ-Related Retinal Toxicity
Patients with systemic lupus erythematosus and hydroxychloroquine-related retinal toxicity had a greater prevalence of antiretinal autoantibodies. Patients with systemic lupus erythematosus (SLE) and ...
1 天
William Blair Remains a Buy on Cabaletta Bio (CABA)
In a report released today, Sami Corwin from William Blair maintained a Buy rating on Cabaletta Bio (CABA – Research Report). The company’s ...
Healio
1 天
Non-invasive, saliva-based Sjögren’s diagnosis model shows good performance
A non-invasive diagnostic model, based partially on saliva samples, distinguished between patients with and without Sjögren’s ...
2 天
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor
Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative ...
6 天
on MSN
Blood test proven to 'detect cancer earlier and reduce deaths'
The blood test for those at high risk of lung cancer could lead to earlier detection and a "major reduction" in deaths, a ...
6 天
Blood test found to 'detect cancer earlier and reduce deaths'
Blood testing people at high risk of lung cancer could reduce the number of deaths, a study has found. University of St ...
6 天
Simple blood test 'could reduce number of lung cancer deaths'
The large-scale trial involved 12,208 smokers and ex-smokers who were aged between 50 and 75 years old and at high risk of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈